An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

Clinical trial NCT06721598 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06721598
Sponsor: National Research Center for Hematology, Russia
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia ALL

Start date: 2025-01-09
Primary completion: 2026-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.